Overview
KLOW Overview
KLOW is a research blend of four separately synthesized peptides in one vial. It combines GHK-Cu (a copper complex of the tripeptide Gly-His-Lys), BPC-157 (a 15-residue linear peptide), thymosin beta-4 (a 43-residue acetylated polypeptide supplied under the TB-500 designation), and KPV (a tripeptide matching the C-terminal end of alpha-melanocyte-stimulating hormone).
Each component keeps its own identity, CAS number, and published literature. Molecular weights range from about 342 g/mol to about 4,963 g/mol, so identity and purity are confirmed per component rather than for the blend as a whole. The format suits in vitro designs that examine several signaling pathways within one system.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Composition | GHK-Cu [X mg] BPC-157 [X mg] Thymosin beta-4 (TB-500) [X mg] KPV [X mg] |
|---|---|
| Total peptide content | [X mg] per vial |
| Sequence | GHK-Cu: Gly-His-Lys, copper(II) complex BPC-157: GEPPPGKPADDAGLV Thymosin beta-4: Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES KPV: Lys-Pro-Val |
| Sequence length | GHK-Cu: 3 residues BPC-157: 15 residues Thymosin beta-4: 43 residues KPV: 3 residues |
| Also known as | GHK-Cu: copper tripeptide-1, prezatide copper BPC-157: PL 14736, bepecin Thymosin beta-4: Tβ4, timbetasin KPV: alpha-MSH (11-13), ACTH (11-13) |
| Molecular formula | GHK-Cu: C14H21CuN6O4 BPC-157: C62H98N16O22 Thymosin beta-4: C212H350N56O78S KPV: C16H30N4O4 |
| Molecular weight | GHK-Cu: 400.90 g/mol BPC-157: 1419.5 g/mol Thymosin beta-4: 4963 g/mol KPV: 342.43 g/mol |
| CAS number | GHK-Cu: 89030-95-5 BPC-157: 137525-51-0 Thymosin beta-4: 77591-33-4 KPV: 67727-97-3 |
| PubChem CID | GHK-Cu: 139035031 BPC-157: 9941957 Thymosin beta-4: 16132341 KPV: 125672 |
| Form | Lyophilized powder |
| Purity | [≥99% by HPLC, per COA] |
| Storage | -20°C or below, sealed and protected from light |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| KLOW - 80 mgJun 19, 2026 | 260528KS503 | View COA |